A case of acute and severe thrombocytopenia due to readministration of rifampicin

J Infect Chemother. 2011 Apr;17(2):288-90. doi: 10.1007/s10156-010-0117-x. Epub 2010 Sep 9.

Abstract

A 49-year-old-woman was diagnosed with tuberculosis of the left humerus. She had received treatment, including rifampicin, for tuberculosis 17 years previously. Treatment was begun with isoniazid, rifampicin, ethambutol, and pyrazinamide, but these were discontinued because of mild neutropenia and thrombocytopenia 2 weeks posttreatment. Rifampicin and ethambutol were readministered after a 4-day interruption; however, generalized purpura appeared several hours later. By the next day, her platelet count was reduced from 160 × 10(3) to 3 × 10(3)/μl. The patient improved rapidly after platelet transfusion and steroid treatment. Readministration of drugs other than rifampicin did not induce thrombocytopenia; therefore, thrombocytopenia was likely due to rifampicin.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / adverse effects*
  • Ethambutol / administration & dosage
  • Female
  • Humans
  • Humerus / microbiology
  • Middle Aged
  • Rifampin / administration & dosage
  • Rifampin / adverse effects*
  • Severity of Illness Index
  • Thrombocytopenia / etiology*
  • Thrombocytopenia / physiopathology
  • Tuberculosis, Osteoarticular / complications*
  • Tuberculosis, Osteoarticular / drug therapy*

Substances

  • Antitubercular Agents
  • Ethambutol
  • Rifampin